NCT00271284View on ClinicalTrials.gov

Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

insulin glulisine / insulin glargine

insulin glargine administered subcutaneously by the patient once a day, in the evening, between 18.30 and 24.00

DRUG

insulin glulisin / insulin detemir

insulin detemir administered subcutaneously by the patient once a day, in the evening, between 18.30 and 24.00

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00271284 - Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients | Biotech Hunter | Biotech Hunter